Sodium 4-phenylbutyrate induces apoptosis of human lung carcinoma cells through activating JNK pathway

Journal of Cellular Biochemistry

Volumn 93, Issue 4, 2004, Pages 819-829

  Zhang, Xing ^a,b   Wei, Lin ^a   Yang, Yu ^a   Yu, Qiang ^a,c  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Apoptosis; JNK; Lung carcinoma; RNA interference; Sodium 4 phenylbutyrate

Indexed keywords

4 PHENYLBUTYRIC ACID; FAS LIGAND; LYMPHOTOXIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; 4-PHENYLBUTYRIC ACID; ARYLBUTYRIC ACID DERIVATIVE; PROTEIN SYNTHESIS INHIBITOR; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL DIFFERENTIATION; CELL SURVIVAL; DRUG EFFECT; ENZYME ACTIVATION; GROWTH DISORDER; HUMAN; LUNG CARCINOMA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA INTERFERENCE; ADENOCARCINOMA; BIOSYNTHESIS; CELL CYCLE G1 PHASE; LUNG TUMOR; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADENOCARCINOMA; APOPTOSIS; CELL LINE, TUMOR; ENZYME ACTIVATION; G1 PHASE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; PHENYLBUTYRATES; PROTEIN SYNTHESIS INHIBITORS; TUMOR NECROSIS FACTORS;

EID: 21744459301     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20173     Document Type: Article

References (38)

1. Alexandrov I, Romanova L, Mushinski F, Nordan R. 1998. Sodium butyrate suppresses apoptosis in human Burkitt lymphomas and murine plasmacytomas bearing c-myc translocations. FEBS Lett 434:209-214.
2. Amin HM, Saeed S, Alkan S. 2001. Histone deacetylase inhibitors induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t(15;17). Br J Haematol 115:287-297.
3. Archacki SR, Angheloiu G, Tian XL, Tan FL, DiPaola N, Shen GQ, Moravec C, Ellis S, Topol EJ, Wang Q. 2003. Identification of new genes differentially expressed in coronary artery disease by expression profiling. Physiol Genomics 15:65-74.
4. Basu S, Kolesnick R. 1998. Stress signals for apoptosis: Ceramide and c-Jun kinase. Oncogene 17:3277-3285.
5. Bernhard D, Ausserlechner MJ, Tonko M, Loffler M, Hartmann BL, Csordas A, Kofler R. 1999. Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts. FASEB J 13:1991-2001.
6. Boldt S, Weidle UH, Kolch W. 2002. The role of MAPK pathways in the action of chemotherapeutic drugs. Carcinogenesis 23:1831-1838.
7. Brummelkamp TR, Bernards R, Agami R. 2002. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2:243-247.
8. Carducci MA, Nelson JB, Chan-Tack KM, Ayyagari SR, Sweatt WH, Campbell PA, Nelson WG, Simons JW. 1996. Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate. Clin Cancer Res 2:379-387.
9. Carducci MA, Gilbert J, Bowling MK, Noe D, Eisenberger MA, Sinibaldi V, Zabelina Y, Chen TL, Grochow LB, Donehower RC. 2001. A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule. Clin Cancer Res 7:3047-3055.
10. Cartee L, Vrana JA, Wang Z, Park JS, Birrer M, Fisher PB, Grant S, Dent P. 2000. Inhibition of the mitogen activated protein kinase pathway potentiates radiation-induced cell killing via cell cycle arrest at the G2/M transition and independently of increased signaling by the JNK/c-Jun pathway. Int J Oncol 16:413-422.
11. Chao JI, Yang JL. 2001. Opposite roles of ERK and p38 mitogen-activated protein kinases in cadmium-induced genotoxicity and mitotic arrest. Chem Res Toxicol 14: 1193-1202.
12. Chen JS, Faller DV, Spanjaard RA. 2003. Short-chain fatty acid inhibitors of histone deacetylases: Promising anticancer therapeutics? Curr Cancer Drug Targets 3:219-236.
13. Chopin V, Toulon RA, Jouy N, Le Bourhis X. 2002. Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells. Br J Pharmacol 135:79-86.
14. Chuang SM, Wang IC, Yang JL. 2000. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium. Carcinogenesis 21:1423-1432.
15. Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N, Miki T, Gutkind JS. 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81:1137-1146.
16. Ding Q, Wang Q, Evers BM. 2001. Alterations of MAPK activities associated with intestinal cell differentiation. Biochem Biophys Res Commun 284:282-288.
17. Furukawa T, Kubota T, Suto A, Takahara T, Yamaguchi H, Takeuchi T, Kase S, Kodaira S, Ishibiki K, Kitajima M. 1991. Clinical usefulness of chemosensitivity testing using the MTT assay. J Surg Oncol 48:188-193.
18. Gekle M, Schwerdt G, Freudinger R, Mildenberger S, Wilflingseder D, Pollack V, Dander M, Schramek H. 2000. Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar concentrations. J Pharmacol Exp Ther 293:837-844.
19. Gillenwater A, Xu XC, Estrov Y, Sacks PG, Lotan D, Lotan R. 1998. Modulation of galectin-1 content in human head and neck squamous carcinoma cells by sodium butyrate. Int J Cancer 75:217-224.
20. Greenberg AK, Basu S, Hu J, Yie TA, Tchou-Wong KM, Rom WN, Lee TC. 2002. Selective p38 activation in human non-small cell lung cancer. Am J Respir Cell Mol Biol 26:558-564.
21. Hague A, Diaz GD, Hicks DJ, Krajewski S, Reed JC, Paraskeva C. 1997. bcl-2 and bak may play a pivotal role in sodium butyrate-induced apoptosis in colonic epithelial cells; however overexpression of bcl-2 does not protect against bak-mediated apoptosis. Int J Cancer 72:898-905.
22. Higashi K. 1999. [The aged and stress response]. J Uoeh 21:157-169.
23. Husain SS, Szabo IL, Pai R, Soreghan B, Jones MK, Tarnawski AS. 2001. MAPK (ERK2) kinase-A key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth. Life Sci 69:3045-3054.
24. Janson W, Brandner G, Siegel J. 1997. Butyrate modulates DNA-damage-induced p53 response by induction of p53-independent differentiation and apoptosis. Oncogene 15: 1395-1406.
25. Liu ZG, Hsu H, Goeddel DV, Karin M. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87:565-576.
26. Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, Ho A, Morony S, Capparelli C, Van G, Kaufman S, van der Heiden A, Itie A, Wakeham A, Khoo W, Sasaki T, Cao Z, Penninger JM, Paige CJ, Lacey DL, Dunstan CR, Boyle WJ, Goeddel DV, Mak TW. 1999. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 13:1015-1024.
27. Mandal M, Wu X, Kumar R. 1997. Bcl-2 deregulation leads to inhibition of sodium butyrate-induced apoptosis in human colorectal carcinoma cells. Carcinogenesis 18: 229-232.
28. Minden A, Lin A, Claret FX, Abo A, Karin M. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81:1147-1157.
29. Rosette C, Karin M. 1996. Ultraviolet light and osmotic stress: Activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274:1194-1197.
30. Sawa H, Murakami H, Ohshima Y, Sugino T, Nakajyo T, Kisanuki T, Tamura Y, Satone A, Ide W, Hashimoto I, Kamada H. 2001. Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad. Brain Tumor Pathol 18:109-114.
31. Svechnikova I, Gray SG, Kundrotiene J, Ponthan F, Kogner P, Ekstrom TJ. 2003. Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate. Int J Oncol 22:579-588.
32. Trock B, Lanza E, Greenwald P. 1990. Dietary fiber, vegetables, and colon cancer: Critical review and meta-analyses of the epidemiologic evidence. J Natl Cancer Inst 82:650-661.
33. Turner ND, Zhang J, Davidson LA, Lupton JR, Chapkin RS. 2002. Oncogenic ras alters sensitivity of mouse colonocytes to butyrate and fatty acid mediated growth arrest and apoptosis. Cancer Lett 186:29-35.
34. Wang Q, Wieder R. 2004. All-trans retinoic acid potentiates Taxotere-induced cell death mediated by Jun N-terminal kinase in breast cancer cells. Oncogene 23:426-433.
35. Wisdom R, Johnson RS, Moore C. 1999. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J 18:188-197.
36. Yeh WC, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, de la Pompa JL, Ferrick D, Hum B, Iscove N, Ohashi P, Rothe M, Goeddel DV, Mak TW. 1997. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7:715-725.
37. Yu Y, Black JB, Goldsmith CS, Browning PJ, Bhalla K, Offermann MK. 1999. Induction of human herpesvirus-8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells. J Gen Virol 80:83-90.
38. Zornig M, Hueber A, Baum W, Evan G. 2001. Apoptosis regulators and their role in tumorigenesis. Biochim Biophys Acta 1551:F1-F37.